Loading…

Cost-effectiveness of Using Quantiferon Gold (QFT-G)® versus Tuberculin Skin Test (TST) among U.S. and Foreign Born Populations at a Public Health Department Clinic with a Low Prevalence of Tuberculosis

Objective The purpose of this study was to determine the cost benefit to routinely using QFT‐G versus the standard TST for screening U.S. and foreign born populations at a public health department clinic with a low prevalence of tuberculosis. Design and Sample A comparative cost analysis of the mone...

Full description

Saved in:
Bibliographic Details
Published in:Public health Nursing 2014-03, Vol.31 (2), p.144-152
Main Authors: Iqbal, Ayesha Z., Leighton, Jenelle, Anthony, John, Knaup, Richard C., Peters, Eleanor B., Bailey, Thomas C.
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c4243-a63d9d629cef06adbae86ec788a348c2ad6b10dcdc4136f6ba97ca01d79c25513
cites cdi_FETCH-LOGICAL-c4243-a63d9d629cef06adbae86ec788a348c2ad6b10dcdc4136f6ba97ca01d79c25513
container_end_page 152
container_issue 2
container_start_page 144
container_title Public health Nursing
container_volume 31
creator Iqbal, Ayesha Z.
Leighton, Jenelle
Anthony, John
Knaup, Richard C.
Peters, Eleanor B.
Bailey, Thomas C.
description Objective The purpose of this study was to determine the cost benefit to routinely using QFT‐G versus the standard TST for screening U.S. and foreign born populations at a public health department clinic with a low prevalence of tuberculosis. Design and Sample A comparative cost analysis of the monetization between QFT‐G and TST was conducted: Data from the health department's Chest Clinic patients seen in 2007 were used to model cost predictions. Measures The net costs of screening, x‐rays, the standard 9 months of latent tuberculosis infection treatment, laboratory, and administration for U.S. born patients and foreign born patients were investigated. Results There are no apparent cost savings for U.S. born individuals, but due to the higher specificity of QFT‐G for foreign born BCG‐vaccinated individuals, there are unnecessary expenditures associated with the higher number of false positives incurred when using TST compared with QFT‐G on 1,000 foreign born individuals (69%, 18%). Conclusion QFT‐G is cost‐effective and should be used at local health department clinics that want to achieve savings in screening and treating those suspected of having TB infection, especially for high‐risk populations such as foreign born individuals.
doi_str_mv 10.1111/phn.12083
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1523398951</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3250396141</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4243-a63d9d629cef06adbae86ec788a348c2ad6b10dcdc4136f6ba97ca01d79c25513</originalsourceid><addsrcrecordid>eNqNks9uEzEQxlcIREvhwAugkbgkh03t9f490kASUFRSZQNHy-udbd1u7GDvJvSleAiuvBQOaXpAQmIOHsnzm08zmi8IXlMyoj7ONzd6RCOSsyfBKU2iJKRxnD4NTknGstAXipPghXO3hBCWROnz4CSKKc1ylp0Gv8bGdSE2DcpObVGjc2AaWDmlr-GqF7pTDVqjYWraGgZXkzKcDn_-gC1a1zso-wqt7FulYXnnnxJdB4NyWQ5BrI2XWI2WIxC6homxqK41XBirYWE2fSs6ZbQD0YGARV-1SsIMRdvdwHvcCNutUXcw9tK-sFP-W8Dc7GBhcSta1BL3gx4HME65l8GzRrQOXz3ks2A1-VCOZ-H88_Tj-N08lHEUs1CkrC7qNCokNiQVdSUwT1FmeS5YnMtI1GlFSS1rGVOWNmklikwKQuuskFGSUHYWDA66G2u-9X5jvlZOYtsKjaZ33J-AsSIv_gslcZyQqCg8-vYv9Nb0VvtF9lSeZFGcJJ4aHihpjXMWG76xai3sPaeE783AvRn4HzN49s2DYl-tsX4kj9f3wPkB2KkW7_-txBezy6NkeOhQrsPvjx3C3vHUmy3hXy-nfPlpln6ZLAkv2G-WiM6M</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1508572455</pqid></control><display><type>article</type><title>Cost-effectiveness of Using Quantiferon Gold (QFT-G)® versus Tuberculin Skin Test (TST) among U.S. and Foreign Born Populations at a Public Health Department Clinic with a Low Prevalence of Tuberculosis</title><source>Wiley:Jisc Collections:Wiley Read and Publish Open Access 2024-2025 (reading list)</source><creator>Iqbal, Ayesha Z. ; Leighton, Jenelle ; Anthony, John ; Knaup, Richard C. ; Peters, Eleanor B. ; Bailey, Thomas C.</creator><creatorcontrib>Iqbal, Ayesha Z. ; Leighton, Jenelle ; Anthony, John ; Knaup, Richard C. ; Peters, Eleanor B. ; Bailey, Thomas C.</creatorcontrib><description>Objective The purpose of this study was to determine the cost benefit to routinely using QFT‐G versus the standard TST for screening U.S. and foreign born populations at a public health department clinic with a low prevalence of tuberculosis. Design and Sample A comparative cost analysis of the monetization between QFT‐G and TST was conducted: Data from the health department's Chest Clinic patients seen in 2007 were used to model cost predictions. Measures The net costs of screening, x‐rays, the standard 9 months of latent tuberculosis infection treatment, laboratory, and administration for U.S. born patients and foreign born patients were investigated. Results There are no apparent cost savings for U.S. born individuals, but due to the higher specificity of QFT‐G for foreign born BCG‐vaccinated individuals, there are unnecessary expenditures associated with the higher number of false positives incurred when using TST compared with QFT‐G on 1,000 foreign born individuals (69%, 18%). Conclusion QFT‐G is cost‐effective and should be used at local health department clinics that want to achieve savings in screening and treating those suspected of having TB infection, especially for high‐risk populations such as foreign born individuals.</description><identifier>ISSN: 0737-1209</identifier><identifier>EISSN: 1525-1446</identifier><identifier>DOI: 10.1111/phn.12083</identifier><identifier>PMID: 24117837</identifier><language>eng</language><publisher>United States: Blackwell Publishing Ltd</publisher><subject>Adolescent ; Adult ; Comparative analysis ; Cost-Benefit Analysis ; Cost-effectiveness ; Emigration and Immigration - statistics &amp; numerical data ; Female ; Health care expenditures ; Humans ; LTBI ; Male ; Medical screening ; Middle Aged ; Nursing ; Prevalence ; Public health ; Public Health - economics ; screening ; Sensitivity and Specificity ; TST ; Tuberculin Test - economics ; Tuberculin Test - methods ; Tuberculosis ; Tuberculosis - diagnosis ; Tuberculosis - epidemiology ; United States - epidemiology ; Young Adult</subject><ispartof>Public health Nursing, 2014-03, Vol.31 (2), p.144-152</ispartof><rights>2013 Wiley Periodicals, Inc.</rights><rights>Copyright Blackwell Publishing Ltd. Mar/Apr 2014</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4243-a63d9d629cef06adbae86ec788a348c2ad6b10dcdc4136f6ba97ca01d79c25513</citedby><cites>FETCH-LOGICAL-c4243-a63d9d629cef06adbae86ec788a348c2ad6b10dcdc4136f6ba97ca01d79c25513</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/24117837$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Iqbal, Ayesha Z.</creatorcontrib><creatorcontrib>Leighton, Jenelle</creatorcontrib><creatorcontrib>Anthony, John</creatorcontrib><creatorcontrib>Knaup, Richard C.</creatorcontrib><creatorcontrib>Peters, Eleanor B.</creatorcontrib><creatorcontrib>Bailey, Thomas C.</creatorcontrib><title>Cost-effectiveness of Using Quantiferon Gold (QFT-G)® versus Tuberculin Skin Test (TST) among U.S. and Foreign Born Populations at a Public Health Department Clinic with a Low Prevalence of Tuberculosis</title><title>Public health Nursing</title><addtitle>Public Health Nurs</addtitle><description>Objective The purpose of this study was to determine the cost benefit to routinely using QFT‐G versus the standard TST for screening U.S. and foreign born populations at a public health department clinic with a low prevalence of tuberculosis. Design and Sample A comparative cost analysis of the monetization between QFT‐G and TST was conducted: Data from the health department's Chest Clinic patients seen in 2007 were used to model cost predictions. Measures The net costs of screening, x‐rays, the standard 9 months of latent tuberculosis infection treatment, laboratory, and administration for U.S. born patients and foreign born patients were investigated. Results There are no apparent cost savings for U.S. born individuals, but due to the higher specificity of QFT‐G for foreign born BCG‐vaccinated individuals, there are unnecessary expenditures associated with the higher number of false positives incurred when using TST compared with QFT‐G on 1,000 foreign born individuals (69%, 18%). Conclusion QFT‐G is cost‐effective and should be used at local health department clinics that want to achieve savings in screening and treating those suspected of having TB infection, especially for high‐risk populations such as foreign born individuals.</description><subject>Adolescent</subject><subject>Adult</subject><subject>Comparative analysis</subject><subject>Cost-Benefit Analysis</subject><subject>Cost-effectiveness</subject><subject>Emigration and Immigration - statistics &amp; numerical data</subject><subject>Female</subject><subject>Health care expenditures</subject><subject>Humans</subject><subject>LTBI</subject><subject>Male</subject><subject>Medical screening</subject><subject>Middle Aged</subject><subject>Nursing</subject><subject>Prevalence</subject><subject>Public health</subject><subject>Public Health - economics</subject><subject>screening</subject><subject>Sensitivity and Specificity</subject><subject>TST</subject><subject>Tuberculin Test - economics</subject><subject>Tuberculin Test - methods</subject><subject>Tuberculosis</subject><subject>Tuberculosis - diagnosis</subject><subject>Tuberculosis - epidemiology</subject><subject>United States - epidemiology</subject><subject>Young Adult</subject><issn>0737-1209</issn><issn>1525-1446</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2014</creationdate><recordtype>article</recordtype><recordid>eNqNks9uEzEQxlcIREvhwAugkbgkh03t9f490kASUFRSZQNHy-udbd1u7GDvJvSleAiuvBQOaXpAQmIOHsnzm08zmi8IXlMyoj7ONzd6RCOSsyfBKU2iJKRxnD4NTknGstAXipPghXO3hBCWROnz4CSKKc1ylp0Gv8bGdSE2DcpObVGjc2AaWDmlr-GqF7pTDVqjYWraGgZXkzKcDn_-gC1a1zso-wqt7FulYXnnnxJdB4NyWQ5BrI2XWI2WIxC6homxqK41XBirYWE2fSs6ZbQD0YGARV-1SsIMRdvdwHvcCNutUXcw9tK-sFP-W8Dc7GBhcSta1BL3gx4HME65l8GzRrQOXz3ks2A1-VCOZ-H88_Tj-N08lHEUs1CkrC7qNCokNiQVdSUwT1FmeS5YnMtI1GlFSS1rGVOWNmklikwKQuuskFGSUHYWDA66G2u-9X5jvlZOYtsKjaZ33J-AsSIv_gslcZyQqCg8-vYv9Nb0VvtF9lSeZFGcJJ4aHihpjXMWG76xai3sPaeE783AvRn4HzN49s2DYl-tsX4kj9f3wPkB2KkW7_-txBezy6NkeOhQrsPvjx3C3vHUmy3hXy-nfPlpln6ZLAkv2G-WiM6M</recordid><startdate>201403</startdate><enddate>201403</enddate><creator>Iqbal, Ayesha Z.</creator><creator>Leighton, Jenelle</creator><creator>Anthony, John</creator><creator>Knaup, Richard C.</creator><creator>Peters, Eleanor B.</creator><creator>Bailey, Thomas C.</creator><general>Blackwell Publishing Ltd</general><general>Wiley Subscription Services, Inc</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T2</scope><scope>7TS</scope><scope>ASE</scope><scope>C1K</scope><scope>FPQ</scope><scope>K6X</scope><scope>NAPCQ</scope><scope>7X8</scope></search><sort><creationdate>201403</creationdate><title>Cost-effectiveness of Using Quantiferon Gold (QFT-G)® versus Tuberculin Skin Test (TST) among U.S. and Foreign Born Populations at a Public Health Department Clinic with a Low Prevalence of Tuberculosis</title><author>Iqbal, Ayesha Z. ; Leighton, Jenelle ; Anthony, John ; Knaup, Richard C. ; Peters, Eleanor B. ; Bailey, Thomas C.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4243-a63d9d629cef06adbae86ec788a348c2ad6b10dcdc4136f6ba97ca01d79c25513</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2014</creationdate><topic>Adolescent</topic><topic>Adult</topic><topic>Comparative analysis</topic><topic>Cost-Benefit Analysis</topic><topic>Cost-effectiveness</topic><topic>Emigration and Immigration - statistics &amp; numerical data</topic><topic>Female</topic><topic>Health care expenditures</topic><topic>Humans</topic><topic>LTBI</topic><topic>Male</topic><topic>Medical screening</topic><topic>Middle Aged</topic><topic>Nursing</topic><topic>Prevalence</topic><topic>Public health</topic><topic>Public Health - economics</topic><topic>screening</topic><topic>Sensitivity and Specificity</topic><topic>TST</topic><topic>Tuberculin Test - economics</topic><topic>Tuberculin Test - methods</topic><topic>Tuberculosis</topic><topic>Tuberculosis - diagnosis</topic><topic>Tuberculosis - epidemiology</topic><topic>United States - epidemiology</topic><topic>Young Adult</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Iqbal, Ayesha Z.</creatorcontrib><creatorcontrib>Leighton, Jenelle</creatorcontrib><creatorcontrib>Anthony, John</creatorcontrib><creatorcontrib>Knaup, Richard C.</creatorcontrib><creatorcontrib>Peters, Eleanor B.</creatorcontrib><creatorcontrib>Bailey, Thomas C.</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Health and Safety Science Abstracts (Full archive)</collection><collection>Physical Education Index</collection><collection>British Nursing Index</collection><collection>Environmental Sciences and Pollution Management</collection><collection>British Nursing Index (BNI) (1985 to Present)</collection><collection>British Nursing Index</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>MEDLINE - Academic</collection><jtitle>Public health Nursing</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Iqbal, Ayesha Z.</au><au>Leighton, Jenelle</au><au>Anthony, John</au><au>Knaup, Richard C.</au><au>Peters, Eleanor B.</au><au>Bailey, Thomas C.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Cost-effectiveness of Using Quantiferon Gold (QFT-G)® versus Tuberculin Skin Test (TST) among U.S. and Foreign Born Populations at a Public Health Department Clinic with a Low Prevalence of Tuberculosis</atitle><jtitle>Public health Nursing</jtitle><addtitle>Public Health Nurs</addtitle><date>2014-03</date><risdate>2014</risdate><volume>31</volume><issue>2</issue><spage>144</spage><epage>152</epage><pages>144-152</pages><issn>0737-1209</issn><eissn>1525-1446</eissn><abstract>Objective The purpose of this study was to determine the cost benefit to routinely using QFT‐G versus the standard TST for screening U.S. and foreign born populations at a public health department clinic with a low prevalence of tuberculosis. Design and Sample A comparative cost analysis of the monetization between QFT‐G and TST was conducted: Data from the health department's Chest Clinic patients seen in 2007 were used to model cost predictions. Measures The net costs of screening, x‐rays, the standard 9 months of latent tuberculosis infection treatment, laboratory, and administration for U.S. born patients and foreign born patients were investigated. Results There are no apparent cost savings for U.S. born individuals, but due to the higher specificity of QFT‐G for foreign born BCG‐vaccinated individuals, there are unnecessary expenditures associated with the higher number of false positives incurred when using TST compared with QFT‐G on 1,000 foreign born individuals (69%, 18%). Conclusion QFT‐G is cost‐effective and should be used at local health department clinics that want to achieve savings in screening and treating those suspected of having TB infection, especially for high‐risk populations such as foreign born individuals.</abstract><cop>United States</cop><pub>Blackwell Publishing Ltd</pub><pmid>24117837</pmid><doi>10.1111/phn.12083</doi><tpages>9</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0737-1209
ispartof Public health Nursing, 2014-03, Vol.31 (2), p.144-152
issn 0737-1209
1525-1446
language eng
recordid cdi_proquest_miscellaneous_1523398951
source Wiley:Jisc Collections:Wiley Read and Publish Open Access 2024-2025 (reading list)
subjects Adolescent
Adult
Comparative analysis
Cost-Benefit Analysis
Cost-effectiveness
Emigration and Immigration - statistics & numerical data
Female
Health care expenditures
Humans
LTBI
Male
Medical screening
Middle Aged
Nursing
Prevalence
Public health
Public Health - economics
screening
Sensitivity and Specificity
TST
Tuberculin Test - economics
Tuberculin Test - methods
Tuberculosis
Tuberculosis - diagnosis
Tuberculosis - epidemiology
United States - epidemiology
Young Adult
title Cost-effectiveness of Using Quantiferon Gold (QFT-G)® versus Tuberculin Skin Test (TST) among U.S. and Foreign Born Populations at a Public Health Department Clinic with a Low Prevalence of Tuberculosis
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-06T16%3A41%3A57IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Cost-effectiveness%20of%20Using%20Quantiferon%20Gold%20(QFT-G)%C2%AE%20versus%20Tuberculin%20Skin%20Test%20(TST)%20among%20U.S.%20and%20Foreign%20Born%20Populations%20at%20a%20Public%20Health%20Department%20Clinic%20with%20a%20Low%20Prevalence%20of%20Tuberculosis&rft.jtitle=Public%20health%20Nursing&rft.au=Iqbal,%20Ayesha%20Z.&rft.date=2014-03&rft.volume=31&rft.issue=2&rft.spage=144&rft.epage=152&rft.pages=144-152&rft.issn=0737-1209&rft.eissn=1525-1446&rft_id=info:doi/10.1111/phn.12083&rft_dat=%3Cproquest_cross%3E3250396141%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c4243-a63d9d629cef06adbae86ec788a348c2ad6b10dcdc4136f6ba97ca01d79c25513%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1508572455&rft_id=info:pmid/24117837&rfr_iscdi=true